Quantum-Si (NASDAQ:QSI) Upgraded to "Hold" at Wall Street Zen

Key Points

• Wall Street Zen upgraded Quantum-Si from “Sell” to “Hold.” The broader analyst consensus is also “Hold,” with two Buy ratings, one Hold, one Sell, and a consensus price target of $2.50.
• Quantum-Si shares opened at $1.46, compared with a 52-week range of $0.69 to $2.42. The company reported a quarterly loss of $0.11 per share and revenue of $0.34 million.
• Institutional investors have increased their involvement, with hedge funds and other institutions owning approximately 39.9% of the company. Quantum-Si develops single-molecule protein analysis technology through its Platinum platform.

Quantum-Si (NASDAQ:QSI - Get Free Report) was upgraded by Wall Street Zen from a "sell" rating to a "hold" rating in a note issued to investors on Tuesday, Wall Street Zen reports.

QSI has been the subject of several other research reports. HC Wainwright set a $4.00 target price on Quantum-Si in a research report on Friday, October 9th. Alliance Global Partners reissued a "buy" rating on shares of Quantum-Si in a research report on Friday, August 14th. Finally, Weiss Ratings upgraded shares of Quantum-Si from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Thursday, September 24th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $2.50.

Quantum-Si Stock Performance

Shares of QSI opened at $1.46 on Tuesday. Quantum-Si has a 52-week low of $0.69 and a 52-week high of $2.42. The stock has a market capitalization of $319.56 million, a price-to-earnings ratio of -3.17 and a beta of 3.21. The stock's 50-day simple moving average is $0.97 and its 200 day simple moving average is $0.96.

Quantum-Si (NASDAQ:QSI - Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). The company had revenue of $0.34 million for the quarter, compared to analysts' expectations of $0.30 million. Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. On average, research analysts forecast that Quantum-Si will post -0.47 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Hollencrest Capital Management increased its position in shares of Quantum-Si by 301.1% during the first quarter. Hollencrest Capital Management now owns 40,111 shares of the company's stock worth $31,000 after acquiring an additional 30,111 shares during the period. Renaissance Technologies LLC bought a new stake in Quantum-Si during the first quarter valued at about $91,000. Green Alpha Advisors LLC bought a new stake in shares of Quantum-Si in the 2nd quarter valued at about $41,000. IPG Investment Advisors LLC purchased a new position in Quantum-Si in the second quarter worth $27,000. Finally, WINTON GROUP Ltd purchased a new position in Quantum-Si during the 2nd quarter worth $67,000. Hedge funds and other institutional investors own 39.90% of the company's stock.

Quantum-Si Company Profile

Quantum-Si Incorporated NASDAQ: QSI is a life sciences technology company focused on transforming protein analysis through next-generation proteomics. The company develops tools designed to identify and characterize proteins at the single-molecule level, with potential applications in drug discovery, translational research, diagnostics development and precision medicine.

Its primary offering is the Platinum platform, which combines a benchtop sequencing instrument, semiconductor-based technology, consumables and data-analysis software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.